SOURCE: Dynavax Technologies

Dynavax Technologies

March 02, 2016 16:05 ET

Dynavax to Participate in the Cowen and Company 36th Annual Health Care Conference

BERKELEY, CA--(Marketwired - March 02, 2016) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Gray, Dynavax's chief executive officer, will present at the Cowen and Company 36th Annual Health Care Conference next week in Boston, MA. The presentation will be webcast live and will occur on Wednesday, March 9, 2016 at 10:40 a.m. EST.

The live or replayed versions of the webcast will be available by visiting the "Investors" section of the Dynavax website.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious diseases and oncology. Dynavax's lead product candidates are HEPLISAV-B™, a Phase 3 investigational adult hepatitis B vaccine and SD-101, an investigational cancer immunotherapeutic currently in several Phase 1/2 studies. For more information, visit www.dynavax.com.

Contact Information

  • Contact:
    Michael Ostrach
    Chief Financial Officer
    510-665-7257
    Email contact